Gram-negative bacterial resistance: evolving patterns and treatment paradigms

Marin H Kollef1

  • 1Pulmonary and Critical Care Division, Washington University School of Medicine, St. Louis, Missouri 63110, USA. mkollef@im.wustl.edu

Insights

Timely antibiotic treatment is crucial for treating nosocomial pneumonia, especially Gram-negative infections. Responsible antibiotic use is vital to preserve future treatment effectiveness against resistant bacteria like Pseudomonas aeruginosa.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Antimicrobial Stewardship

Background:

  • Nosocomial pneumonia treatment success hinges on prompt, appropriate antibiotic therapy.
  • Gram-negative bacteria, particularly Pseudomonas aeruginosa, are common causes and present significant resistance challenges.
  • Increasing antimicrobial resistance complicates empirical treatment decisions and impacts patient mortality.

Purpose of the Study:

  • To highlight the critical role of initial antibiotic selection in managing nosocomial pneumonia.
  • To discuss the challenges posed by drug-resistant Gram-negative bacteria, including Pseudomonas aeruginosa.
  • To emphasize the importance of antimicrobial stewardship for preserving future treatment efficacy.

Main Methods:

  • Review of current strategies for treating nosocomial pneumonia.
  • Analysis of the impact of antibiotic resistance on treatment outcomes.
  • Discussion of combination therapy and de-escalation approaches.

Main Results:

  • Inappropriate antibiotic courses are linked to increased mortality in nosocomial pneumonia.
  • Pseudomonas aeruginosa infections are particularly difficult due to intrinsic and adaptive resistance.
  • Combination therapy followed by de-escalation shows promise in managing these infections.

Conclusions:

  • Effective management of nosocomial pneumonia requires timely and adequate initial antibiotic therapy.
  • Responsible antibiotic use in intensive care units is essential for combating resistance.
  • Preserving the effectiveness of current antibiotics is critical for future patient care.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Genomic DNA in Prokaryotes00:46

Genomic DNA in Prokaryotes

The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...